» Articles » PMID: 23712106

Validation of the Amsterdam IADL Questionnaire©, a New Tool to Measure Instrumental Activities of Daily Living in Dementia

Overview
Specialties Neurology
Public Health
Date 2013 May 29
PMID 23712106
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study describes the validation of a new instrument measuring instrumental activities of daily living (IADL), the Amsterdam IADL Questionnaire© (a registered copyright of the Alzheimer Center of the VU University Medical Center). This informant-based tool aimed at detecting IADL problems in incipient dementia was previously found to have a high internal consistency and test-retest reliability.

Methods: Patients and their informants who visited the Alzheimer Center of the VU University Medical Center were included in this study. Item response theory was used to estimate the individuals' trait levels as a measure of IADL disability. Construct validity was tested by correlating estimated trait levels with clinical and demographic measures using Pearson's or Kendall's τ correlation coefficients. Additionally, estimated trait levels between patients with and without dementia and between patients with early- and late-onset dementia were compared using independent t tests.

Results: A total of 206 informants of patients completed the Amsterdam IADL Questionnaire. The correlations between estimated trait levels and other measures were in concordance with previously formed hypotheses. Patients diagnosed with dementia (n = 93) had higher estimated trait levels than patients without dementia (n = 96), Cohen's effect size, d = 1.04, t(187) = 7.1, p < 0.001. We found no differences between early- and late-onset dementia patients.

Conclusions: Results suggest that the Amsterdam IADL Questionnaire is a reliable and valid instrument in the evaluation of dementia.

Citing Articles

Perspective: Minimal clinically important difference (MCID) and Alzheimer's disease clinical trials.

Cummings J Alzheimers Dement (N Y). 2025; 11(1):e70059.

PMID: 40065918 PMC: 11891559. DOI: 10.1002/trc2.70059.


The Implementation of Infant Anoesis and Adult Autonoesis in the Retrogenesis and Staging System of the Neurocognitive Disorders: A Proposal for a Multidimensional Person-Centered Model.

Pirani A Geriatrics (Basel). 2025; 10(1).

PMID: 39997519 PMC: 11854936. DOI: 10.3390/geriatrics10010020.


Brain health clinics - An evolving clinical pathway?.

Butters A, Blackman J, Farouk H, Meky S, A Newson M, Lemke T J Prev Alzheimers Dis. 2025; 12(3):100051.

PMID: 39904691 PMC: 11861520. DOI: 10.1016/j.tjpad.2024.100051.


RADAR-AD: assessment of multiple remote monitoring technologies for early detection of Alzheimer's disease.

Lentzen M, Vairavan S, Muurling M, Alepopoulos V, Atreya A, Boada M Alzheimers Res Ther. 2025; 17(1):29.

PMID: 39865315 PMC: 11771057. DOI: 10.1186/s13195-025-01675-0.


A systematic review of psychometric properties of questionnaires assessing activities of daily living among older adults with neurocognitive disorders.

Osman A, Radman D, Belchior P, Gelinas I Aust Occup Ther J. 2025; 72(1):e13013.

PMID: 39853749 PMC: 11758263. DOI: 10.1111/1440-1630.13013.